• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 24, 2024 at 11:32: AM
via Eli Lilly (LLY.N) said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.

article source
 




Top Bottom
Back
Quote